Effect of methylphenidate on apathy in patients with Alzheimer disease: the admet 2 randomized clinical trial
Typical treatment of prediabetes involves lifestyle changes such as quitting smoking, weight management, more physical activity, and a balanced diet
Medicare GLP-1 Bridge Launching July 1, 2026, the Bridge offers eligible Medicare beneficiaries Wegovy for weight loss at $50 per month through December 31, 2027, outside the Part D benefit
In another study, it has been confirmed that treatment of AR mice with caffeoylxanthiazonoside-coated gold nanoparticles reduced the IFN- and IL-4 levels in nasal lavage fluid
Emerging indications (MASH, neuroprotection, seizure modulation, cravings, fertility/PCOS, pulmonary outcomes) expand the therapeutic horizon, while future pipelines (oral GLP-1s, triple agonists, amylin co-agonists) promise refined personalization and access